326 results on '"Seppälä, Toni T."'
Search Results
2. Circulating metabolome landscape in Lynch syndrome
3. Genome-wide polygenic risk scores for colorectal cancer have implications for risk-based screening
4. Multiplexed analysis of macrophage polarisation in pulmonary metastases of microsatellite stable colorectal cancer
5. In vivo CRISPR screening identifies geranylgeranyl diphosphate as a pancreatic cancer tumor growth dependency
6. Tertiary lymphoid structures in pulmonary metastases of microsatellite stable colorectal cancer
7. Quantitative Multiplexed Analysis of Indoleamine 2,3-Dioxygenase (IDO) and Arginase-1 (ARG1) Expression and Myeloid Cell Infiltration in Colorectal Cancer
8. Dominantly inherited micro-satellite instable cancer – the four Lynch syndromes - an EHTG, PLSD position statement
9. Spatially resolved multimarker evaluation of CD274 (PD-L1)/PDCD1 (PD-1) immune checkpoint expression and macrophage polarisation in colorectal cancer
10. Dominantly inherited micro-satellite instable cancer - the four Lynch syndromes - an EHTG, PLSD position statement
11. The prognostic role of tumor budding and tumor-stroma ratio in pulmonary metastasis of colorectal carcinoma
12. Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database
13. Lynch Syndrome Genetics and Clinical Implications
14. Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines
15. Prognostic significance of spatial and density analysis of T lymphocytes in colorectal cancer
16. Figure S2 from Circulating miRNA Signature Predicts Cancer Incidence in Lynch Syndrome—A Pilot Study
17. Data from Circulating miRNA Signature Predicts Cancer Incidence in Lynch Syndrome—A Pilot Study
18. Table S11 from Circulating miRNA Signature Predicts Cancer Incidence in Lynch Syndrome—A Pilot Study
19. Methods S1 from Circulating miRNA Signature Predicts Cancer Incidence in Lynch Syndrome—A Pilot Study
20. Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EHTG-ESCP revision
21. The Different Immune Profiles of Normal Colonic Mucosa in Cancer-Free Lynch Syndrome Carriers and Lynch Syndrome Colorectal Cancer Patients
22. Circulating microRNA signature predicts cancer incidence in Lynch syndrome – a pilot study
23. Solving for Chemotherapeutic Sensitivity: Adapting “Black Box” Methods to Study Patient-Derived Tumor Organoids
24. Can Pancreatic Organoids Help in the Treatment of Pancreatic Cancer?
25. Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study
26. Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report
27. Prospective observational data informs understanding and future management of Lynch syndrome: insights from the Prospective Lynch Syndrome Database (PLSD)
28. High immune cell infiltration predicts improved survival in cholangiocarcinoma.
29. Multiplexed analysis of macrophage polarisation in pulmonary metastases of microsatellite stable colorectal cancer
30. Circulating metabolome landscape in Lynch Syndrome
31. Therapeutic Targeting of Oncogene-induced Transcription-Replication Conflicts in Pancreatic Ductal Adenocarcinoma
32. Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
33. Editorial: Identification, risk stratification, and optimized management for Lynch Syndrome
34. Hereditary colorectal, gastric, and pancreatic cancer: comprehensive review
35. Immunological and prognostic significance of tumour necrosis in colorectal cancer
36. Supplementary Figure from Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up
37. Data from Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up
38. Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report
39. Patient-derived Organoid Pharmacotyping is a Clinically Tractable Strategy for Precision Medicine in Pancreatic Cancer
40. Hereditary colorectal, gastric, and pancreatic cancer : comprehensive review
41. Supplementary Figure from Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response
42. Supplementary Table from Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response
43. Data from Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response
44. Supplementary Data from Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response
45. Tumor-independent Detection of Inherited Mismatch Repair Deficiency for the Diagnosis of Lynch Syndrome with High Specificity and Sensitivity
46. Clinical characteristics of pancreatic and biliary tract cancers in Lynch syndrome: A retrospective analysis from the Finnish National Lynch Syndrome Research Registry
47. Clinical characteristics of pancreatic and biliary tract cancers in Lynch syndrome : A retrospective analysis from the Finnish National Lynch Syndrome Research Registry
48. Response to Tolva et al.
49. Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report
50. CD3+ and CD8+ T-Cell-Based Immune Cell Score and PD-(L)1 Expression in Pulmonary Metastases of Microsatellite Stable Colorectal Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.